Overview This page contains the latest trade data of Heparin, salts, for therapeutic use. In 2022, Heparin, salts, for therapeutic use were the world's 691st most traded product, with a total trade of $5.54B. Between 2021 and 2022 the exports of Heparin, salts, for therapeutic use decreased by -5.41%, from $5.86B to $5.54B. Trade in Heparin, salts, for therapeutic use represent 0.023% of total world trade.
Heparin, salts, for therapeutic use are a part of Glands and Other Organs.
Exports In 2022 the top exporters of Heparin, salts, for therapeutic use were China ($1.26B), United States ($757M), France ($750M), Singapore ($716M), and Spain ($381M).
Imports In 2022 the top importers of Heparin, salts, for therapeutic use were France ($1.1B), Singapore ($671M), United States ($419M), Spain ($319M), and China ($266M).
Ranking Heparin, salts, for therapeutic use ranks 1371st in the Product Complexity Index (PCI).
Description Heparin is a medication which is used to prevent blood clots. It is usually administered by injection or as a shot. Salts are used to control acid-base balance in the body, as well as for other therapeutic purposes.